1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "1816989-16-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-128587


    CDK Cancer
    Mevociclib (SY-1365) is a potent and first-in-class selective CDK7 inhibitor, with a Ki of 17.4 nM. Mevociclib exhibits anti-proliferative and apoptotic effects in solid tumor cell lines. Mevociclib possesses anti-tumor activity in hematological and multiple aggressive solid tumors.